Filing Flows › Bio-Techne (TECH) › Q1 FY27 › vs Q4 FY26
Bio-Techne (TECH) Q1 FY27 vs Q4 FY26 (quarter over quarter)
Bio-Techne's revenue fell $21.5M (-7%) from $321M in Q4 FY26 to $300M in Q1 FY27. The biggest changes: Product and Services −$30.1M (-10%); Royalty +$8.6M (+147%). Gross margin 65.6% against 65.8% (-0.2 pts).
Bio-Techne, Q1 FY27: revenue $300M (+5% year over year), operating margin 12.2%, net earnings $28.3M, operating cash flow $73.1M. The chart draws each line against Q4 FY26, the increases inside each band.
Margins
| Q1 FY27 | Q4 FY26 | Change | |
|---|---|---|---|
| Gross margin | 65.6% | 65.8% | -0.2 pts |
| Operating margin | 12.2% | 23.1% | -10.9 pts |
| Net margin | 9.4% | 17.0% | -7.6 pts |
| Free cash flow margin | 22.4% | 27.1% | -4.6 pts |
Every line
| Line | Q1 FY27 | Q4 FY26 | Change | % |
|---|---|---|---|---|
| Consumables | $237M | $261M | −$23.5M | -9% |
| Instruments | $25.5M | $31.5M | −$6.0M | -19% |
| Services | $22.5M | $23.1M | −$595K | -3% |
| Product and Services | $285M | $315M | −$30.1M | -10% |
| Royalty | $14.5M | $5.9M | $8.6M | +147% |
| Revenue | $300M | $321M | −$21.5M | -7% |
| Gross profit | $197M | $211M | −$14.8M | -7% |
| Cost of revenue | $103M | $110M | −$6.7M | -6% |
| Operating profit | $36.6M | $74.3M | −$37.7M | -51% |
| Operating expenses | $160M | $137M | $22.9M | +17% |
| Pre-tax earnings | $34.7M | $70.7M | −$36.0M | -51% |
| Other expense, net | $1.9M | $3.6M | −$1.7M | -47% |
| Research & development | $26.3M | $23.9M | $2.4M | +10% |
| SG&A | $134M | $113M | $20.5M | +18% |
| Net earnings | $28.3M | $54.6M | −$26.3M | -48% |
| Income tax | $6.4M | $16.1M | −$9.7M | -60% |
| Depreciation & amortization | $23.7M | $24.1M | −$415K | -2% |
| Share-based compensation | $13.4M | $5.2M | $8.2M | +156% |
| Working capital & other | $7.7M | $11.4M | −$3.7M | -33% |
| Operating cash flow | $73.1M | $95.4M | −$22.3M | -23% |
| Free cash flow (OCF − capex) | $67.2M | $86.9M | −$19.7M | -23% |
| Capital expenditures | $5.9M | $8.5M | −$2.6M | -30% |
Questions
How much did Bio-Techne's revenue grow quarter over quarter in Q1 FY27?
Bio-Techne's revenue fell $21.5M (-7%) from $321M in Q4 FY26 to $300M in Q1 FY27.
What drove Bio-Techne's revenue change in Q1 FY27?
Product and Services −$30.1M (-10%); Royalty +$8.6M (+147%).